Cargando…
Commentary on “Remission in pediatric Graves’ disease treated with antithyroid drug and the risk factors associated with relapse”
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Korean Society of Pediatric Endocrinology
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816460/ https://www.ncbi.nlm.nih.gov/pubmed/36567460 http://dx.doi.org/10.6065/apem.2222019edi04 |
| _version_ | 1784864536194449408 |
|---|---|
| author | Kim, Ji Hyun |
| author_facet | Kim, Ji Hyun |
| author_sort | Kim, Ji Hyun |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9816460 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Korean Society of Pediatric Endocrinology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-98164602023-01-11 Commentary on “Remission in pediatric Graves’ disease treated with antithyroid drug and the risk factors associated with relapse” Kim, Ji Hyun Ann Pediatr Endocrinol Metab Editorial Korean Society of Pediatric Endocrinology 2022-12 2022-12-31 /pmc/articles/PMC9816460/ /pubmed/36567460 http://dx.doi.org/10.6065/apem.2222019edi04 Text en © 2022 Annals of Pediatric Endocrinology & Metabolism https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Editorial Kim, Ji Hyun Commentary on “Remission in pediatric Graves’ disease treated with antithyroid drug and the risk factors associated with relapse” |
| title | Commentary on “Remission in pediatric Graves’ disease treated with antithyroid drug and the risk factors associated with relapse” |
| title_full | Commentary on “Remission in pediatric Graves’ disease treated with antithyroid drug and the risk factors associated with relapse” |
| title_fullStr | Commentary on “Remission in pediatric Graves’ disease treated with antithyroid drug and the risk factors associated with relapse” |
| title_full_unstemmed | Commentary on “Remission in pediatric Graves’ disease treated with antithyroid drug and the risk factors associated with relapse” |
| title_short | Commentary on “Remission in pediatric Graves’ disease treated with antithyroid drug and the risk factors associated with relapse” |
| title_sort | commentary on “remission in pediatric graves’ disease treated with antithyroid drug and the risk factors associated with relapse” |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816460/ https://www.ncbi.nlm.nih.gov/pubmed/36567460 http://dx.doi.org/10.6065/apem.2222019edi04 |
| work_keys_str_mv | AT kimjihyun commentaryonremissioninpediatricgravesdiseasetreatedwithantithyroiddrugandtheriskfactorsassociatedwithrelapse |